ARID1B is a specific vulnerability in ARID1A-mutant cancers
2014 · Nature Medicine · 418 citations
https://doi.org/10.1038/nm.3480
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
8
Papers
1.2K
Citations
5
h-index
5
i10-index
Katherine Helming is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Chromatin Remodeling and Cancer & Cancer Mechanisms and Therapy & Protein Degradation and Inhibitors. The author has an h-index of 5, co-authored 7 publications.
Click to start Chat